511 related articles for article (PubMed ID: 34721430)
1. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
2. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.
Messmann JJ; Reisser T; Leithäuser F; Lutz MB; Debatin KM; Strauss G
Blood; 2015 Aug; 126(9):1138-48. PubMed ID: 26185131
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.
Scheurer J; Reisser T; Leithäuser F; Messmann JJ; Holzmann K; Debatin KM; Strauss G
Clin Exp Immunol; 2020 Dec; 202(3):407-422. PubMed ID: 32681646
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
7. Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.
Choi W; Ji YW; Ham HY; Yeo A; Noh H; Jin SE; Song JS; Kim HC; Kim EK; Lee HK
J Leukoc Biol; 2016 Dec; 100(6):1453-1463. PubMed ID: 27370015
[TBL] [Abstract][Full Text] [Related]
8. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
[TBL] [Abstract][Full Text] [Related]
9. Early myeloid-derived suppressor cells (HLA-DR
Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244
[TBL] [Abstract][Full Text] [Related]
10. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
[TBL] [Abstract][Full Text] [Related]
11. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.
D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT
Front Immunol; 2020; 11():989. PubMed ID: 32528476
[TBL] [Abstract][Full Text] [Related]
13. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.
Zhao Y; Shen XF; Cao K; Ding J; Kang X; Guan WX; Ding YT; Liu BR; Du JF
Front Immunol; 2018; 9():282. PubMed ID: 29497426
[TBL] [Abstract][Full Text] [Related]
15. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
16. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.
E S; Seth A; Vogel P; Sommers M; Ong T; Pillai AB
Blood; 2017 Jun; 129(22):3017-3030. PubMed ID: 28351935
[TBL] [Abstract][Full Text] [Related]
18. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.
Wang D; Yu Y; Haarberg K; Fu J; Kaosaard K; Nagaraj S; Anasetti C; Gabrilovich D; Yu XZ
Biol Blood Marrow Transplant; 2013 May; 19(5):692-702. PubMed ID: 23376089
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
Su Z; Zhang Y; Ni P; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
[TBL] [Abstract][Full Text] [Related]
20. MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.
Lim JY; Lee YK; Lee SE; Ju JM; Eom KS; Kim YJ; Chung NG; Jeong DC; Park G; Choi EY; Min CK
Mucosal Immunol; 2016 May; 9(3):730-43. PubMed ID: 26442657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
